Reprocessed SUD Recall Underlines Sec. 301 Branding Concerns – OEMs
A recent recall by reprocessor MedSurg Solutions could spur FDA to change its format for recall notices
More from Archive
More from Medtech Insight
• By
Broad participation by EU member states in a new pilot to test a unified procedure for evaluating applications for combined drug and IVD studies shows they recognize its value, says Monique Al, vice-chair of the Clinical Trials Coordination Group.
• By
MedTech Europe is ready to become involved and shape Europe’s Life Sciences Strategy and help drive regulatory simplification from the top to make the EU “the world’s most attractive place for life sciences by 2030.”
• By
The UK government’s blueprint to deliver an NHS "fit for the future" was released on July 3.